nodes	percent_of_prediction	percent_of_DWPC	metapath
Alogliptin—CYP2D6—Temsirolimus—kidney cancer	0.138	0.169	CbGbCtD
Alogliptin—CYP3A4—Everolimus—kidney cancer	0.13	0.159	CbGbCtD
Alogliptin—CYP3A4—Temsirolimus—kidney cancer	0.088	0.108	CbGbCtD
Alogliptin—CYP2D6—Pazopanib—kidney cancer	0.0727	0.0889	CbGbCtD
Alogliptin—CYP2D6—Erlotinib—kidney cancer	0.0518	0.0635	CbGbCtD
Alogliptin—CYP3A4—Pazopanib—kidney cancer	0.0462	0.0566	CbGbCtD
Alogliptin—CYP2D6—Sorafenib—kidney cancer	0.0422	0.0516	CbGbCtD
Alogliptin—CYP2D6—Vinblastine—kidney cancer	0.0416	0.051	CbGbCtD
Alogliptin—CYP3A4—Erlotinib—kidney cancer	0.033	0.0404	CbGbCtD
Alogliptin—CYP3A4—Paclitaxel—kidney cancer	0.0302	0.0369	CbGbCtD
Alogliptin—CYP3A4—Sorafenib—kidney cancer	0.0268	0.0328	CbGbCtD
Alogliptin—CYP3A4—Vinblastine—kidney cancer	0.0265	0.0324	CbGbCtD
Alogliptin—CYP3A4—Vincristine—kidney cancer	0.026	0.0319	CbGbCtD
Alogliptin—CYP2D6—Doxorubicin—kidney cancer	0.0256	0.0313	CbGbCtD
Alogliptin—CYP3A4—Sunitinib—kidney cancer	0.0217	0.0266	CbGbCtD
Alogliptin—CYP3A4—Doxorubicin—kidney cancer	0.0163	0.0199	CbGbCtD
Alogliptin—Pancreatitis acute—Everolimus—kidney cancer	0.00723	0.0583	CcSEcCtD
Alogliptin—DPP4—Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)—PAX6—kidney cancer	0.00493	0.12	CbGpPWpGaD
Alogliptin—Linagliptin—ABCB1—kidney cancer	0.00484	1	CrCbGaD
Alogliptin—Pancreatitis acute—Paclitaxel—kidney cancer	0.00405	0.0327	CcSEcCtD
Alogliptin—Diabetes mellitus—Temsirolimus—kidney cancer	0.00374	0.0302	CcSEcCtD
Alogliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—PAX6—kidney cancer	0.00364	0.0888	CbGpPWpGaD
Alogliptin—DPP4—Incretin synthesis, secretion, and inactivation—PAX6—kidney cancer	0.00324	0.079	CbGpPWpGaD
Alogliptin—Diabetes mellitus—Everolimus—kidney cancer	0.00278	0.0225	CcSEcCtD
Alogliptin—Nasopharyngitis—Pazopanib—kidney cancer	0.00274	0.0221	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Temsirolimus—kidney cancer	0.00261	0.0211	CcSEcCtD
Alogliptin—Pancreatitis—Pazopanib—kidney cancer	0.0026	0.021	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Temsirolimus—kidney cancer	0.00249	0.0201	CcSEcCtD
Alogliptin—Hypoglycaemia—Everolimus—kidney cancer	0.00248	0.02	CcSEcCtD
Alogliptin—CYP3A4—urine—kidney cancer	0.00225	0.168	CbGeAlD
Alogliptin—CYP2D6—urine—kidney cancer	0.00221	0.165	CbGeAlD
Alogliptin—Nasopharyngitis—Everolimus—kidney cancer	0.00217	0.0175	CcSEcCtD
Alogliptin—Erythema multiforme—Temsirolimus—kidney cancer	0.00213	0.0172	CcSEcCtD
Alogliptin—Hypoglycaemia—Sunitinib—kidney cancer	0.00207	0.0167	CcSEcCtD
Alogliptin—Pancreatitis—Everolimus—kidney cancer	0.00205	0.0166	CcSEcCtD
Alogliptin—Pancreatitis—Erlotinib—kidney cancer	0.00198	0.016	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Everolimus—kidney cancer	0.00195	0.0157	CcSEcCtD
Alogliptin—Nasopharyngitis—Sorafenib—kidney cancer	0.00188	0.0152	CcSEcCtD
Alogliptin—DPP4—nephron tubule—kidney cancer	0.00185	0.139	CbGeAlD
Alogliptin—Nasopharyngitis—Sunitinib—kidney cancer	0.00181	0.0146	CcSEcCtD
Alogliptin—Angioedema—Temsirolimus—kidney cancer	0.00179	0.0145	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Erlotinib—kidney cancer	0.00179	0.0144	CcSEcCtD
Alogliptin—Pancreatitis—Sorafenib—kidney cancer	0.00178	0.0144	CcSEcCtD
Alogliptin—Pancreatitis—Sunitinib—kidney cancer	0.00171	0.0138	CcSEcCtD
Alogliptin—DPP4—renal system—kidney cancer	0.00168	0.126	CbGeAlD
Alogliptin—DPP4—kidney—kidney cancer	0.00163	0.122	CbGeAlD
Alogliptin—Upper respiratory tract infection—Sunitinib—kidney cancer	0.00162	0.0131	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Sorafenib—kidney cancer	0.00161	0.013	CcSEcCtD
Alogliptin—Anaphylactic shock—Temsirolimus—kidney cancer	0.0016	0.0129	CcSEcCtD
Alogliptin—DPP4—cortex of kidney—kidney cancer	0.00159	0.119	CbGeAlD
Alogliptin—Stevens-Johnson syndrome—Sunitinib—kidney cancer	0.00155	0.0125	CcSEcCtD
Alogliptin—Erythema multiforme—Erlotinib—kidney cancer	0.00153	0.0123	CcSEcCtD
Alogliptin—DPP4—Peptide hormone metabolism—MME—kidney cancer	0.0015	0.0367	CbGpPWpGaD
Alogliptin—Stevens-Johnson syndrome—Dactinomycin—kidney cancer	0.00146	0.0118	CcSEcCtD
Alogliptin—Hypoglycaemia—Paclitaxel—kidney cancer	0.00139	0.0112	CcSEcCtD
Alogliptin—Erythema multiforme—Sorafenib—kidney cancer	0.00137	0.0111	CcSEcCtD
Alogliptin—Angioedema—Everolimus—kidney cancer	0.00133	0.0108	CcSEcCtD
Alogliptin—Erythema multiforme—Sunitinib—kidney cancer	0.00132	0.0107	CcSEcCtD
Alogliptin—Diabetes mellitus—Capecitabine—kidney cancer	0.00128	0.0103	CcSEcCtD
Alogliptin—Erythema multiforme—Dactinomycin—kidney cancer	0.00125	0.0101	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.00124	0.01	CcSEcCtD
Alogliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CTNNB1—kidney cancer	0.00123	0.03	CbGpPWpGaD
Alogliptin—CYP3A4—Aflatoxin activation and detoxification—ACY1—kidney cancer	0.00122	0.0297	CbGpPWpGaD
Alogliptin—Nasopharyngitis—Paclitaxel—kidney cancer	0.00122	0.00981	CcSEcCtD
Alogliptin—Hypersensitivity—Temsirolimus—kidney cancer	0.00118	0.00951	CcSEcCtD
Alogliptin—CYP2D6—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.00117	0.0286	CbGpPWpGaD
Alogliptin—Angioedema—Sorafenib—kidney cancer	0.00116	0.00934	CcSEcCtD
Alogliptin—DPP4—Peptide hormone metabolism—ACHE—kidney cancer	0.00115	0.0282	CbGpPWpGaD
Alogliptin—Pancreatitis—Paclitaxel—kidney cancer	0.00115	0.00929	CcSEcCtD
Alogliptin—Angioedema—Sunitinib—kidney cancer	0.00111	0.00898	CcSEcCtD
Alogliptin—DPP4—Peptide hormone metabolism—PAX6—kidney cancer	0.0011	0.0268	CbGpPWpGaD
Alogliptin—DPP4—Incretin synthesis, secretion, and inactivation—CTNNB1—kidney cancer	0.00109	0.0267	CbGpPWpGaD
Alogliptin—DPP4—Peptide hormone metabolism—CTSD—kidney cancer	0.00109	0.0266	CbGpPWpGaD
Alogliptin—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.00109	0.00881	CcSEcCtD
Alogliptin—Erythema multiforme—Gemcitabine—kidney cancer	0.00106	0.00857	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.00104	0.00838	CcSEcCtD
Alogliptin—Anaphylactic shock—Sorafenib—kidney cancer	0.00103	0.00834	CcSEcCtD
Alogliptin—Rash—Temsirolimus—kidney cancer	0.00101	0.00814	CcSEcCtD
Alogliptin—Dermatitis—Temsirolimus—kidney cancer	0.00101	0.00813	CcSEcCtD
Alogliptin—DPP4—Peptide hormone metabolism—BCHE—kidney cancer	0.001	0.0245	CbGpPWpGaD
Alogliptin—Headache—Temsirolimus—kidney cancer	0.001	0.00809	CcSEcCtD
Alogliptin—Nasopharyngitis—Capecitabine—kidney cancer	0.000997	0.00805	CcSEcCtD
Alogliptin—Rash—Pazopanib—kidney cancer	0.00095	0.00767	CcSEcCtD
Alogliptin—Dermatitis—Pazopanib—kidney cancer	0.00095	0.00766	CcSEcCtD
Alogliptin—Headache—Pazopanib—kidney cancer	0.000944	0.00762	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000896	0.00723	CcSEcCtD
Alogliptin—Erythema multiforme—Paclitaxel—kidney cancer	0.000889	0.00717	CcSEcCtD
Alogliptin—Hypersensitivity—Vinblastine—kidney cancer	0.00088	0.0071	CcSEcCtD
Alogliptin—Hypersensitivity—Everolimus—kidney cancer	0.000877	0.00708	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000852	0.00688	CcSEcCtD
Alogliptin—Anaphylactic shock—Vincristine—kidney cancer	0.000841	0.00679	CcSEcCtD
Alogliptin—Diabetes mellitus—Doxorubicin—kidney cancer	0.000826	0.00667	CcSEcCtD
Alogliptin—Urticaria—Sorafenib—kidney cancer	0.000821	0.00662	CcSEcCtD
Alogliptin—Anaphylactic shock—Gemcitabine—kidney cancer	0.000798	0.00644	CcSEcCtD
Alogliptin—CYP2D6—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000786	0.0192	CbGpPWpGaD
Alogliptin—CYP3A4—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000766	0.0187	CbGpPWpGaD
Alogliptin—Hypersensitivity—Sorafenib—kidney cancer	0.000761	0.00614	CcSEcCtD
Alogliptin—Rash—Everolimus—kidney cancer	0.00075	0.00606	CcSEcCtD
Alogliptin—Dermatitis—Everolimus—kidney cancer	0.00075	0.00605	CcSEcCtD
Alogliptin—Headache—Vinblastine—kidney cancer	0.000748	0.00604	CcSEcCtD
Alogliptin—Angioedema—Paclitaxel—kidney cancer	0.000748	0.00603	CcSEcCtD
Alogliptin—Headache—Everolimus—kidney cancer	0.000746	0.00602	CcSEcCtD
Alogliptin—Hypoglycaemia—Doxorubicin—kidney cancer	0.000737	0.00594	CcSEcCtD
Alogliptin—Hypersensitivity—Sunitinib—kidney cancer	0.000732	0.00591	CcSEcCtD
Alogliptin—Erythema multiforme—Capecitabine—kidney cancer	0.000729	0.00589	CcSEcCtD
Alogliptin—Rash—Erlotinib—kidney cancer	0.000724	0.00584	CcSEcCtD
Alogliptin—Dermatitis—Erlotinib—kidney cancer	0.000723	0.00584	CcSEcCtD
Alogliptin—Headache—Erlotinib—kidney cancer	0.000719	0.00581	CcSEcCtD
Alogliptin—Hypersensitivity—Dactinomycin—kidney cancer	0.000693	0.0056	CcSEcCtD
Alogliptin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000668	0.00539	CcSEcCtD
Alogliptin—Rash—Sorafenib—kidney cancer	0.000651	0.00526	CcSEcCtD
Alogliptin—Dermatitis—Sorafenib—kidney cancer	0.000651	0.00525	CcSEcCtD
Alogliptin—Headache—Sorafenib—kidney cancer	0.000647	0.00522	CcSEcCtD
Alogliptin—Nasopharyngitis—Doxorubicin—kidney cancer	0.000643	0.00519	CcSEcCtD
Alogliptin—Rash—Sunitinib—kidney cancer	0.000627	0.00506	CcSEcCtD
Alogliptin—Dermatitis—Sunitinib—kidney cancer	0.000626	0.00505	CcSEcCtD
Alogliptin—Headache—Sunitinib—kidney cancer	0.000623	0.00503	CcSEcCtD
Alogliptin—Hypersensitivity—Vincristine—kidney cancer	0.000619	0.005	CcSEcCtD
Alogliptin—Pancreatitis—Doxorubicin—kidney cancer	0.000609	0.00492	CcSEcCtD
Alogliptin—Rash—Dactinomycin—kidney cancer	0.000593	0.00479	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000577	0.00466	CcSEcCtD
Alogliptin—DPP4—Metabolism of proteins—EIF5B—kidney cancer	0.000575	0.014	CbGpPWpGaD
Alogliptin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—kidney cancer	0.000555	0.0136	CbGpPWpGaD
Alogliptin—CYP3A4—renal system—kidney cancer	0.000549	0.0411	CbGeAlD
Alogliptin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000549	0.00443	CcSEcCtD
Alogliptin—CYP2D6—renal system—kidney cancer	0.000541	0.0405	CbGeAlD
Alogliptin—CYP3A4—kidney—kidney cancer	0.000531	0.0398	CbGeAlD
Alogliptin—Urticaria—Paclitaxel—kidney cancer	0.000531	0.00428	CcSEcCtD
Alogliptin—Rash—Vincristine—kidney cancer	0.00053	0.00428	CcSEcCtD
Alogliptin—Dermatitis—Vincristine—kidney cancer	0.00053	0.00427	CcSEcCtD
Alogliptin—Headache—Vincristine—kidney cancer	0.000527	0.00425	CcSEcCtD
Alogliptin—CYP2D6—kidney—kidney cancer	0.000523	0.0391	CbGeAlD
Alogliptin—DPP4—Peptide hormone metabolism—POMC—kidney cancer	0.000519	0.0127	CbGpPWpGaD
Alogliptin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000514	0.0125	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—CUL7—kidney cancer	0.000512	0.0125	CbGpPWpGaD
Alogliptin—Rash—Gemcitabine—kidney cancer	0.000503	0.00406	CcSEcCtD
Alogliptin—Dermatitis—Gemcitabine—kidney cancer	0.000502	0.00406	CcSEcCtD
Alogliptin—Headache—Gemcitabine—kidney cancer	0.0005	0.00403	CcSEcCtD
Alogliptin—Hypersensitivity—Paclitaxel—kidney cancer	0.000492	0.00397	CcSEcCtD
Alogliptin—DPP4—Metabolism of proteins—HSPA9—kidney cancer	0.000489	0.0119	CbGpPWpGaD
Alogliptin—Erythema multiforme—Doxorubicin—kidney cancer	0.00047	0.00379	CcSEcCtD
Alogliptin—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	0.000436	0.0106	CbGpPWpGaD
Alogliptin—Urticaria—Capecitabine—kidney cancer	0.000435	0.00351	CcSEcCtD
Alogliptin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	0.000431	0.0105	CbGpPWpGaD
Alogliptin—CYP2D6—Melatonin metabolism and effects—ACHE—kidney cancer	0.000428	0.0104	CbGpPWpGaD
Alogliptin—Rash—Paclitaxel—kidney cancer	0.000421	0.0034	CcSEcCtD
Alogliptin—Dermatitis—Paclitaxel—kidney cancer	0.000421	0.0034	CcSEcCtD
Alogliptin—Headache—Paclitaxel—kidney cancer	0.000418	0.00338	CcSEcCtD
Alogliptin—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000416	0.0101	CbGpPWpGaD
Alogliptin—Hypersensitivity—Capecitabine—kidney cancer	0.000404	0.00326	CcSEcCtD
Alogliptin—DPP4—Metabolism of proteins—MUC4—kidney cancer	0.000399	0.00973	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—ST3GAL2—kidney cancer	0.000379	0.00925	CbGpPWpGaD
Alogliptin—DPP4—Peptide hormone metabolism—CTNNB1—kidney cancer	0.000371	0.00905	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—EEF2—kidney cancer	0.000371	0.00904	CbGpPWpGaD
Alogliptin—Anaphylactic shock—Doxorubicin—kidney cancer	0.000353	0.00285	CcSEcCtD
Alogliptin—CYP2D6—Xenobiotics—CYP1A1—kidney cancer	0.000348	0.00849	CbGpPWpGaD
Alogliptin—Rash—Capecitabine—kidney cancer	0.000346	0.00279	CcSEcCtD
Alogliptin—Dermatitis—Capecitabine—kidney cancer	0.000345	0.00279	CcSEcCtD
Alogliptin—Headache—Capecitabine—kidney cancer	0.000343	0.00277	CcSEcCtD
Alogliptin—CYP2D6—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000334	0.00816	CbGpPWpGaD
Alogliptin—CYP2D6—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.00033	0.00805	CbGpPWpGaD
Alogliptin—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000329	0.00803	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—ACY1—kidney cancer	0.00032	0.00781	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—MME—kidney cancer	0.000284	0.00693	CbGpPWpGaD
Alogliptin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000281	0.00687	CbGpPWpGaD
Alogliptin—Urticaria—Doxorubicin—kidney cancer	0.000281	0.00227	CcSEcCtD
Alogliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000272	0.00663	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—RPL14—kidney cancer	0.000264	0.00644	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—HSPD1—kidney cancer	0.000264	0.00644	CbGpPWpGaD
Alogliptin—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	0.000261	0.00637	CbGpPWpGaD
Alogliptin—Hypersensitivity—Doxorubicin—kidney cancer	0.00026	0.0021	CcSEcCtD
Alogliptin—CYP2D6—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.000258	0.0063	CbGpPWpGaD
Alogliptin—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.000247	0.00604	CbGpPWpGaD
Alogliptin—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.000237	0.00578	CbGpPWpGaD
Alogliptin—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	0.000227	0.00555	CbGpPWpGaD
Alogliptin—Rash—Doxorubicin—kidney cancer	0.000223	0.0018	CcSEcCtD
Alogliptin—Dermatitis—Doxorubicin—kidney cancer	0.000223	0.0018	CcSEcCtD
Alogliptin—Headache—Doxorubicin—kidney cancer	0.000221	0.00179	CcSEcCtD
Alogliptin—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000219	0.00534	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—ACHE—kidney cancer	0.000218	0.00531	CbGpPWpGaD
Alogliptin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000216	0.00526	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—EIF4EBP1—kidney cancer	0.000215	0.00525	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—ACY1—kidney cancer	0.000209	0.0051	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—PAX6—kidney cancer	0.000207	0.00506	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—CTSD—kidney cancer	0.000206	0.00503	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—BCHE—kidney cancer	0.00019	0.00463	CbGpPWpGaD
Alogliptin—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000182	0.00443	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—ALDH1A1—kidney cancer	0.000175	0.00428	CbGpPWpGaD
Alogliptin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.00017	0.00414	CbGpPWpGaD
Alogliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000162	0.00394	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—IGF2—kidney cancer	0.000147	0.00358	CbGpPWpGaD
Alogliptin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000144	0.00352	CbGpPWpGaD
Alogliptin—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000142	0.00348	CbGpPWpGaD
Alogliptin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000119	0.0029	CbGpPWpGaD
Alogliptin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000117	0.00286	CbGpPWpGaD
Alogliptin—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	0.000117	0.00285	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	0.000115	0.0028	CbGpPWpGaD
Alogliptin—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000108	0.00263	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—GSTT1—kidney cancer	0.000103	0.00251	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—POMC—kidney cancer	9.8e-05	0.00239	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—PTGS1—kidney cancer	9.65e-05	0.00236	CbGpPWpGaD
Alogliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	9.44e-05	0.0023	CbGpPWpGaD
Alogliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	9.32e-05	0.00227	CbGpPWpGaD
Alogliptin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	8.73e-05	0.00213	CbGpPWpGaD
Alogliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	7.65e-05	0.00187	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—GSTP1—kidney cancer	7.14e-05	0.00174	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	7.04e-05	0.00172	CbGpPWpGaD
Alogliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	7.04e-05	0.00172	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—CTNNB1—kidney cancer	7e-05	0.00171	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—GSTT1—kidney cancer	6.73e-05	0.00164	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—GSTM1—kidney cancer	6.56e-05	0.0016	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	6.47e-05	0.00158	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—PTGS1—kidney cancer	6.31e-05	0.00154	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	6.22e-05	0.00152	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	6.13e-05	0.0015	CbGpPWpGaD
Alogliptin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.71e-05	0.00139	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ACY1—kidney cancer	5.47e-05	0.00133	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—GSTP1—kidney cancer	4.67e-05	0.00114	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PDHB—kidney cancer	4.65e-05	0.00114	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—POMC—kidney cancer	4.64e-05	0.00113	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	4.6e-05	0.00112	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CCBL1—kidney cancer	4.37e-05	0.00107	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—GSTM1—kidney cancer	4.29e-05	0.00105	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	4.23e-05	0.00103	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	4.06e-05	0.000992	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	4.01e-05	0.000979	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PPAT—kidney cancer	3.79e-05	0.000925	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GLIPR1—kidney cancer	3.79e-05	0.000925	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ACY1—kidney cancer	3.58e-05	0.000873	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—FH—kidney cancer	3.52e-05	0.00086	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—APRT—kidney cancer	3.52e-05	0.00086	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GPC3—kidney cancer	3.31e-05	0.000809	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CA2—kidney cancer	3.22e-05	0.000787	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ALAD—kidney cancer	3.14e-05	0.000767	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ST3GAL2—kidney cancer	3.07e-05	0.000748	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PDHB—kidney cancer	3.04e-05	0.000742	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—POMC—kidney cancer	3.03e-05	0.00074	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ALDH1A1—kidney cancer	3e-05	0.000731	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PGK1—kidney cancer	2.87e-05	0.000701	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.87e-05	0.000701	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CCBL1—kidney cancer	2.86e-05	0.000698	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—LDHB—kidney cancer	2.82e-05	0.000688	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PPAT—kidney cancer	2.48e-05	0.000605	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.48e-05	0.000605	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CA9—kidney cancer	2.44e-05	0.000596	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—APRT—kidney cancer	2.3e-05	0.000562	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—FH—kidney cancer	2.3e-05	0.000562	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GPC3—kidney cancer	2.17e-05	0.000529	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CA2—kidney cancer	2.11e-05	0.000514	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CRABP1—kidney cancer	2.08e-05	0.000507	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ALAD—kidney cancer	2.05e-05	0.000501	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2e-05	0.000489	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.96e-05	0.000478	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ITPR2—kidney cancer	1.93e-05	0.000471	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PGK1—kidney cancer	1.88e-05	0.000458	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.88e-05	0.000458	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—LDHB—kidney cancer	1.84e-05	0.00045	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ACHE—kidney cancer	1.76e-05	0.00043	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GSTT1—kidney cancer	1.76e-05	0.00043	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SCARB1—kidney cancer	1.67e-05	0.000407	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PTGS1—kidney cancer	1.65e-05	0.000403	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PSMD7—kidney cancer	1.62e-05	0.000395	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CA9—kidney cancer	1.6e-05	0.00039	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—BCHE—kidney cancer	1.53e-05	0.000374	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.52e-05	0.00037	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.46e-05	0.000357	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CRABP1—kidney cancer	1.36e-05	0.000331	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ITPR2—kidney cancer	1.26e-05	0.000308	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GSTP1—kidney cancer	1.22e-05	0.000298	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ABCB1—kidney cancer	1.16e-05	0.000282	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ACHE—kidney cancer	1.15e-05	0.000281	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GSTT1—kidney cancer	1.15e-05	0.000281	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GSTM1—kidney cancer	1.12e-05	0.000274	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SCARB1—kidney cancer	1.09e-05	0.000266	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PTGS1—kidney cancer	1.08e-05	0.000263	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CYP1A1—kidney cancer	1.06e-05	0.00026	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PSMD7—kidney cancer	1.06e-05	0.000258	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—BCHE—kidney cancer	1e-05	0.000245	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SLC5A5—kidney cancer	9.91e-06	0.000242	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SLC2A1—kidney cancer	9.57e-06	0.000234	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GSTP1—kidney cancer	7.98e-06	0.000195	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—POMC—kidney cancer	7.93e-06	0.000193	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ABCB1—kidney cancer	7.55e-06	0.000184	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GSTM1—kidney cancer	7.33e-06	0.000179	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CYP1A1—kidney cancer	6.95e-06	0.00017	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PTGS2—kidney cancer	6.32e-06	0.000154	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PTEN—kidney cancer	5.51e-06	0.000135	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—POMC—kidney cancer	5.18e-06	0.000127	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PTGS2—kidney cancer	4.13e-06	0.000101	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PIK3CA—kidney cancer	3.89e-06	9.5e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PTEN—kidney cancer	3.61e-06	8.8e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.54e-06	6.21e-05	CbGpPWpGaD
